Relay Therapeutics (RLAY) R&D In Process (2021)
Relay Therapeutics (RLAY) has disclosed R&D In Process for 1 consecutive years, with $123.0 million as the latest value for Q2 2021.
Relay Therapeutics (RLAY) has disclosed R&D In Process for 1 consecutive years, with $123.0 million as the latest value for Q2 2021.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month